Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Takeda Pharmaceutical ADR Rep 0.5 Ord Shs V.TAK


Primary Symbol: TAK

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.


NYSE:TAK - Post by User

Post by GoldDemon88on Nov 15, 2010 9:49am
345 Views
Post# 17706212

Taku Gold raises private placement to $7-million

Taku Gold raises private placement to $7-million

Taku Gold raises private placement to $7-million

2010-11-12 16:35 PT - News Release

An anonymous director reports

TAKU GOLD CORP. INCREASES PRIVATE PLACEMENT UP TO $7,000,000

Further to Taku Gold Corp.'s Stockwatch news release dated Nov. 11, 2010, its proposed brokered private placement will be increased from $5-million up to $7-million through the issuance of up to 6.68 million flow-through units at a price of 42 cents per FT unit and up to 11.06 million units at a price of 38 cents per unit for total gross proceeds of up to $7-million. Each FT unit shall consist of one common share and one-half of one common share purchase warrant. Each unit shall comprise one common share and one warrant. Each whole warrant shall entitle the holder thereof to acquire one common share of the company at a price of 65 cents for a period of 24 months following the closing of the offering.

In all other respects, the company's Stockwatch news release dated Nov. 11, 2010, remains unchanged.

We seek Safe Harbor.

Bullboard Posts